Markets

IREN Shares Rally 6% as Market Awaits CEO Compensation Vote

IREN shares rose 6% last week, recovering from recent losses, as investors weigh a massive CEO equity grant against the company's AI expansion and Russell 1000 listing.

Daniel Marsh · · · 3 min read · 3 views
IREN Shares Rally 6% as Market Awaits CEO Compensation Vote
Mentioned in this article
CLSK $12.85 -0.31% CORZ $23.49 -1.05% IREN $41.14 -1.39% MARA $12.60 -4.69%

IREN Ltd. (NASDAQ:IREN) closed Friday at $41.14, posting a 6.0% weekly gain despite persistent volatility that saw three consecutive sessions swing by 8% or more. The stock remains 10.0% below its June 30 close, reflecting ongoing uncertainty surrounding a controversial equity award to co-CEOs William Roberts and Daniel Roberts.

CEO Compensation in Focus

In a July 8 letter, independent chair David Bartholomew addressed shareholder concerns over the board's grant of 18.2 million restricted stock units (RSUs) to the co-CEOs. Based on Friday's closing price, the units carry a mark-to-market value of approximately $748.7 million, though Bartholomew emphasized that "there is no guaranteed dollar amount and no payout floor." The RSUs vest in four annual tranches, with each batch subject to a two-year lockup after vesting. The final tranche cannot be sold before fiscal 2033, and the executives are not eligible for another equity grant until at least fiscal 2031.

Dilution Concerns and Capital Raises

The award represents 5.1% of IREN's 357.38 million shares outstanding as of April 30 and 73.6% of the 24.73 million shares sold through the company's at-the-market (ATM) program between March 4 and April 30. The ATM sales raised $1.064 billion. While the RSUs do not cause immediate dilution, they could dilute existing shareholders once vested and settled. Unvested RSUs may also be forfeited, reducing the eventual impact.

Market Performance and Index Inclusion

IREN joined the Russell 1000 index on June 26, a milestone that has yet to stabilize the stock. Shares are down 12.9% from their $47.21 close on that date, even with last week's bounce. The Russell 1000 is widely used as a benchmark for large-cap U.S. equities, and inclusion typically attracts passive fund inflows. However, the stock's recent slide suggests that the CEO award and ongoing share sales are weighing on sentiment.

Analyst Action and Revenue Mix

On July 6, Freedom Broker analyst Paul Meeks upgraded IREN to Buy from Hold, maintaining a $58 price target. He lowered revenue forecasts for the June and September quarters, expecting most operating gains to materialize later in the year. IREN's latest quarter showed Bitcoin mining revenue of $111.2 million (77% of total) and AI Cloud Services revenue of $33.6 million (23%). The company posted a net loss of $247.8 million for the quarter and held $2.21 billion in cash as of March 31.

Key Risks Ahead

IREN faces several headwinds: delays in GPU procurement, data center construction, or grid connections could push AI revenue further out. Weaker Bitcoin prices would pressure the core mining business, which still accounts for the majority of sales. The company has flagged potential impairment charges of up to $520 million if it converts more mining assets to AI. Its $6 billion ATM authorization also leaves room for additional stock sales, which could further dilute existing holders.

Looking Ahead

This week brings key U.S. economic data, including consumer inflation on Tuesday, producer prices on Wednesday, and retail sales on Thursday. Strong inflation figures could push bond yields higher, weighing on growth stock valuations. Bitcoin hovered near $64,165 over the weekend, adding another variable for IREN's reopening. The ultimate question for investors is whether AI Cloud revenue can outpace execution costs and share dilution, making the CEO award a pivotal factor in the stock's trajectory.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →